Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Cossarini

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
BMC Infectious Diseases|January 8, 2017
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patientsVincenzo Spagnuolo, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mLNicola Gianotti, Laura Galli, Sara Racca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2012
Monotherapy with atazanavir as a simplification strategy: results from an observational studyFrancesca Cossarini, Stefania Salpietro, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2011
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infectionFrancesca Cossarini, Enzo Boeri, Filippo Canducci, et al.
AIDS (London, England)|May 19, 2015
Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' replyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
AIDS (London, England)|May 19, 2015
Immortal time bias: authors' replyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2011
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirineSilvia Nozza, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|August 28, 2014
Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2010
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trialAlessandro Soria, Anna Danise, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
BMC Infectious Diseases|January 8, 2017
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patientsVincenzo Spagnuolo, Laura Galli, Andrea Poli, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mLNicola Gianotti, Laura Galli, Sara Racca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2012
Monotherapy with atazanavir as a simplification strategy: results from an observational studyFrancesca Cossarini, Stefania Salpietro, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2011
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infectionFrancesca Cossarini, Enzo Boeri, Filippo Canducci, et al.
AIDS (London, England)|May 19, 2015
Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' replyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
AIDS (London, England)|May 19, 2015
Immortal time bias: authors' replyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2011
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirineSilvia Nozza, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|August 28, 2014
Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapyLaura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Pageof 4